Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gliosarcoma | Phase 2 | KR | 24 Jun 2020 | |
Recurrent Glioblastoma | Phase 2 | KR | 24 Jun 2020 |